YILING PHARMACEUTICAL(SZ:002603) Hua Xia Shi Bao·2025-11-23 09:53Core Insights - The core argument presented is that modern scientific technology can help demystify traditional Chinese medicine (TCM) and enhance investor confidence in the TCM innovation sector [2][3] Group 1: Challenges in Traditional Chinese Medicine - The main challenge facing the TCM industry is the "black box" nature of its mechanisms, which deters investors from entering the market [2] - There is a need to use quantifiable data to explain the efficacy of TCM, breaking traditional misconceptions [2] Group 2: Research and Development in TCM - The research on Yiling Pharmaceutical's well-known product Lianhua Qingwen involved the identification of 211 chemical components and the establishment of a multidimensional pharmacological evaluation model [3] - The study demonstrated clear synergistic effects among the components of Lianhua Qingwen, indicating that the absence of any one component would diminish the overall therapeutic effect [3] Group 3: Modernization of TCM - The conclusion drawn from the research is that the value of compound TCM lies not in the inclusion of specific ancient formulas but in the scientific combination of their essences to create a more effective whole [3] - Yiling Pharmaceutical aims to use modern scientific language to explain TCM principles, making its efficacy visible, tangible, and verifiable to attract capital investment [3]